Kidney Transplantation From Hepatitis-C Viraemic Donors:Considerations for Practice in the United Kingdom

Background: Donor hepatitis-C (HCV) infection has historically represented a barrier to kidney transplantation (KT). However, direct-acting antiviral (DAA) medications have revolutionised treatment of chronic HCV infection. Recent American studies have demonstrated that DAA regimes can be used safel...

Descripción completa

Detalles Bibliográficos
Autores principales: Doherty, Daniel T., Athwal, Varinder, Moinuddin, Zia, Augustine, Titus, Prince, Martin, van Dellen, David, Khambalia, Hussein A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110637/
https://www.ncbi.nlm.nih.gov/pubmed/35592447
http://dx.doi.org/10.3389/ti.2022.10277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110637/
https://www.ncbi.nlm.nih.gov/pubmed/35592447
http://dx.doi.org/10.3389/ti.2022.10277

Ejemplares similares